Update on T-Cell Lymphoma Epidemiology.
Chen JJ, Tokumori FC, Del Guzzo C, Kim J, Ruan J.
Curr Hematol Malig Rep. 2024 Jun;19(3):93-103. doi: 10.1007/s11899-024-00727-w. Epub 2024 Mar 7.
Peripheral T-Cell Lymphoma: What's Next?
Yoon SE, Kim WS.
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70069. doi: 10.1002/hon.70069.
Cutaneous T-cell Lymphoma.
Pulitzer M.
Clin Lab Med. 2017 Sep;37(3):527-546. doi: 10.1016/j.cll.2017.06.006.
Angioimmunoblastic T-Cell Lymphoma.
Yabe M, Dogan A, Horwitz SM, Moskowitz AJ.
Cancer Treat Res. 2019;176:99-126. doi: 10.1007/978-3-319-99716-2_5.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Ghilardi G, Fraietta JA, Gerson JN, Van Deerlin VM, Morrissette JJD, Caponetti GC, Paruzzo L, Harris JC, Chong EA, Susanibar Adaniya SP, Svoboda J, Nasta SD, Ugwuanyi OH, Landsburg DJ, Fardella E, Waxman AJ, Chong ER, Patel V, Pajarillo R, Kulikovskaya I, Lieberman DB, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Hexner EO, Barta SK, Porter DL, Garfall AL, Schuster SJ, June CH, Ruella M.
Nat Med. 2024 Apr;30(4):984-989. doi: 10.1038/s41591-024-02826-w. Epub 2024 Jan 24.
Epidemiology of Non-Hodgkin's Lymphoma.
Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P.
Med Sci (Basel). 2021 Jan 30;9(1):5. doi: 10.3390/medsci9010005.
Is it prime time for T-cell lymphoma?
Barta SK.
Blood. 2023 May 4;141(18):2161-2163. doi: 10.1182/blood.2023020004.
Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges.
Robson A, Bakr F, Cabeçadas J.
Am J Dermatopathol. 2024 Jul 1;46(7):399-409. doi: 10.1097/DAD.0000000000002547. Epub 2023 Dec 13.
Primary pulmonary T-cell lymphoma.
Vemuri MB, Rajaram M, Malik A, Toi PC.
J Cancer Res Ther. 2022 Apr-Jun;18(3):843-845. doi: 10.4103/jcrt.jcrt_227_21.
Cutaneous T-cell lymphoma.
Arora S, Gogia A.
Indian J Med Res. 2020 Nov;152(Suppl 1):S48-S49. doi: 10.4103/ijmr.IJMR_1792_19.
